Researchers reverse autism symptoms in mice with epilepsy drugs

The legacy of redlining—the 20th-century mapping practice that denied loans and other services to minorities based on their neighborhoods—continues to resonate in cities. New research from Virginia Commonwealth University and Virginia State University finds a spatial overlap between formerly redlined neighborhoods and violent injuries among youth in the city of Richmond today.

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults.

Sweat does more than just cool down an overheating body. Measuring the chemical makeup of an individual's sweat—specifically the levels of chloride, a chemical component of salt—can serve as an early warning system to help inform the diagnosis of cystic fibrosis, a genetic disease that damages the lungs and digestive system.

A new study has created the first single-cell map of how DNA is regulated and organized inside different cell-types of human fat tissue. The research shows that many genetic risk factors for abdominal obesity reside in epigenomic regions of fat cells, offering clues about how body fat is genetically and epigenetically regulated and how it might be better controlled. The study, by co-first authors Zeyuan (Johnson) Chen and Sankha Subhra Das, is published in Nature Genetics.

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's popular weight-loss drug Wegovy to treat a serious form of fatty liver disease.

A new Northwestern Medicine study has revealed how a common inherited mutation disrupts red blood cell development and sparks inflammation that can lead to leukemia, according to findings published in Nature Communications.

Researchers say the ability to visualize health data in three dimensions can unlock patterns and relationships among predictive biomarkers that conventional data visualization can't convey. That's why Zeeshan Ahmed and his team at Rutgers developed 3D IntelliGenes, an advanced artificial intelligence and machine-learning platform with the ability to visually analyze multiple types of biological and clinical data—known as multiomics.

The robot doctor will see you now? Not for the foreseeable future, anyway.

Findings could lead to earlier detection and treatment for those suffering from the serious eye condition.

A new national study led by researchers from Carleton University and the University of Toronto reveals that older adults living in greener neighborhoods were less likely to experience depression during the early months of the COVID-19 pandemic.

Fewer than half of all adolescents with major depressive episode (MDE) received mental health care in the US in 2022, with the odds of specialist treatment being even lower among marginalized groups, according to a study published in the open-access journal PLOS Mental Health by Su Chen Tan and colleagues at University of Tennessee.

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these protein therapeutics require high doses to be effective and are typically formulated at low concentrations to remain stable, IV infusion has been, until now, the only option.

Older adults often don't realize how vulnerable they are to extreme heat and most aren't prepared for long periods of hot weather, according to a review of more than 40 studies.

Researchers have developed an AI tool that can help doctors predict who might develop a potentially fatal heart condition, just from an ECG.

An innovative method that uses modified versions of a bacterial virus effective at delivering treatments to human cells shows promise as a more inexpensive and efficient way to treat some deadly genetic diseases.

In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the anti-interleukin 4Rα monoclonal antibody stapokibart improves outcomes, according to a study published online Aug. 18 in the Journal of the American Medical Association.

In endometriosis, cells similar to uterine tissue grow outside the uterus. According to researchers in the Penn State Department of Kinesiology who study the disease, endometriosis is often treated as a purely gynecological condition. In a new study, however, they demonstrated how the condition, which affects 10% of women around the world, alters how the body responds to feedback.

A research team at The Ohio State University Wexner Medical Center and College of Medicine led a study that showed mothers who breastfed their babies, especially those diagnosed with diabetes during pregnancy, have a lower risk of heart issues later in life. The study was recently published in Obstetrics & Gynecology.